» Articles » PMID: 23798496

Altered Ca2+ Concentration, Permeability and Buffering in the Myofibre Ca2+ Store of a Mouse Model of Malignant Hyperthermia

Overview
Journal J Physiol
Specialty Physiology
Date 2013 Jun 27
PMID 23798496
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

  Malignant hyperthermia (MH) is linked to mutations in the type 1 ryanodine receptor, RyR1, the Ca2+ channel of the sarcoplasmic reticulum (SR) of skeletal muscle. The Y522S MH mutation was studied for its complex presentation, which includes structurally and functionally altered cell 'cores'. Imaging cytosolic and intra-SR [Ca2+] in muscle cells of heterozygous YS mice we determined Ca2+ release flux activated by clamp depolarization, permeability (P) of the SR membrane (ratio of flux and [Ca2+] gradient) and SR Ca2+ buffering power (B). In YS cells resting [Ca2+]SR was 45% of the value in normal littermates (WT). P was more than doubled, so that initial flux was normal. Measuring [Ca2+]SR(t) revealed dynamic changes in B(t). The alterations were similar to those caused by cytosolic BAPTA, which promotes release by hampering Ca2+-dependent inactivation (CDI). The [Ca2+] transients showed abnormal 'breaks', decaying phases after an initial rise, traced to a collapse in flux and P. Similar breaks occurred in WT myofibres with calsequestrin reduced by siRNA; calsequestrin content, however, was normal in YS muscle. Thus, the Y522S mutation causes greater openness of the RyR1, lowers resting [Ca2+]SR and alters SR Ca2+ buffering in a way that copies the functional instability observed upon reduction of calsequestrin content. The similarities with the effects of BAPTA suggest that the mutation, occurring near the cytosolic vestibule of the channel, reduces CDI as one of its primary effects. The unstable SR buffering, mimicked by silencing of calsequestrin, may help precipitate the loss of Ca2+ control that defines a fulminant MH event.

Citing Articles

Muscle calcium stress cleaves junctophilin1, unleashing a gene regulatory program predicted to correct glucose dysregulation.

Tammineni E, Figueroa L, Manno C, Varma D, Kraeva N, Ibarra C Elife. 2023; 12.

PMID: 36724092 PMC: 9891728. DOI: 10.7554/eLife.78874.


Mutations in proteins involved in E-C coupling and SOCE and congenital myopathies.

Rossi D, Catallo M, Pierantozzi E, Sorrentino V J Gen Physiol. 2022; 154(9).

PMID: 35980353 PMC: 9391951. DOI: 10.1085/jgp.202213115.


Molecular mechanism of the severe MH/CCD mutation Y522S in skeletal ryanodine receptor (RyR1) by cryo-EM.

Iyer K, Hu Y, Klose T, Murayama T, Samso M Proc Natl Acad Sci U S A. 2022; 119(30):e2122140119.

PMID: 35867837 PMC: 9335238. DOI: 10.1073/pnas.2122140119.


Altered Ca Handling and Oxidative Stress Underlie Mitochondrial Damage and Skeletal Muscle Dysfunction in Aging and Disease.

Michelucci A, Liang C, Protasi F, Dirksen R Metabolites. 2021; 11(7).

PMID: 34203260 PMC: 8304741. DOI: 10.3390/metabo11070424.


Adaptive thermogenesis enhances the life-threatening response to heat in mice with an Ryr1 mutation.

Wang H, Lee C, Yee R, Groom L, Friedman I, Babcock L Nat Commun. 2020; 11(1):5099.

PMID: 33037202 PMC: 7547078. DOI: 10.1038/s41467-020-18865-z.


References
1.
Wang Y, Xu L, Duan H, Pasek D, Eu J, Meissner G . Knocking down type 2 but not type 1 calsequestrin reduces calcium sequestration and release in C2C12 skeletal muscle myotubes. J Biol Chem. 2006; 281(22):15572-81. DOI: 10.1074/jbc.M600090200. View

2.
Pizarro G, Rios E . How source content determines intracellular Ca2+ release kinetics. Simultaneous measurement of [Ca2+] transients and [H+] displacement in skeletal muscle. J Gen Physiol. 2004; 124(3):239-58. PMC: 2233888. DOI: 10.1085/jgp.200409071. View

3.
Melzer W, Rios E, Schneider M . A general procedure for determining the rate of calcium release from the sarcoplasmic reticulum in skeletal muscle fibers. Biophys J. 1987; 51(6):849-63. PMC: 1330019. DOI: 10.1016/S0006-3495(87)83413-6. View

4.
Sztretye M, Yi J, Figueroa L, Zhou J, Royer L, Allen P . Measurement of RyR permeability reveals a role of calsequestrin in termination of SR Ca(2+) release in skeletal muscle. J Gen Physiol. 2011; 138(2):231-47. PMC: 3149434. DOI: 10.1085/jgp.201010592. View

5.
Sztretye M, Yi J, Figueroa L, Zhou J, Royer L, Rios E . D4cpv-calsequestrin: a sensitive ratiometric biosensor accurately targeted to the calcium store of skeletal muscle. J Gen Physiol. 2011; 138(2):211-29. PMC: 3149433. DOI: 10.1085/jgp.201010591. View